Biotheranostics jobs
WebThis test was developed and its performance characteristics determined by Biotheranostics, Inc. lt has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes, and should not be regarded as experimental or investigational. How this information is used to guide patient care is the ... WebMar 12, 2024 · Biotheranostics, Inc. is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. ... (858) 587-5874 What is Hugo Rossi’s latest job experience? Hugo Rossi’s latest job experience is Sales Director, Oncology at …
Biotheranostics jobs
Did you know?
WebBiotheranostics Work Here? Claim Your Company Benefits New Biotheranostics Open Jobs Are you ready to level up your career? Check out these open roles at … WebFeb 13, 2024 · Biotheranostics, Inc. is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. ... Match relevance is based on profile similarity to job title and location job title and industry people with the same last name. …
WebBrowse jobs in Fawn Creek, Kansas from 1,000s of job boards and employer websites by city. Juju makes your Fawn Creek job search faster and more comprehensive. WebMar 31, 2016 · Jobs. grade C. Based on employment rates, job and business growth, and cost of living. Median Household Income. $58,992. National. $69,021. Search for Jobs in …
WebBioTheranostics General Information. Description. Developer of commercial-stage molecular diagnostics intended to guide cancer treatment. The company develops and commercializes proprietary molecular-based diagnostic, prognostic and predictive tests that provide physicians with actionable information to help to guide cancer treatment, … WebJun 29, 2024 · The Breast Cancer Index test, made by Biotheranostics, analyzes the activity of 11 genes to help predict the risk of early-stage, hormone-receptor-positive breast cancer coming back 5 to 10 years after diagnosis. The test can help women and their doctors decide if extending hormonal therapy 5 more years (for a total of 10 years of …
WebBiotheranostics is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic, and predictive tests that support physicians in the treatment of cancer patients. Biotheranostics is a leader in the development of evidence-based biomarkers to address unmet medical needs, and the Company has set the ...
WebBrowse 4 CALIFORNIA BIOTHERANOSTICS jobs from companies (hiring now) with openings. Find job opportunities near you and apply! ontstofferWebSep 16, 2024 · Glassdoor has 24 bioTheranostics reviews submitted anonymously by bioTheranostics employees. Read employee reviews and ratings on Glassdoor to … iot by stcWebJan 6, 2024 · On Monday, it announced acquisition of Somatex Medical for $64 million, a buy also in the women's health space. Hologic's $230 million valuation is roughly seven times the $33 million of revenue Biotheranostics generated in 2024 and roughly six times the revenue range of high $30 million to low $40 million projected for 2024, according to ... ontstopper wc productiot by nptelWebBiotheranostics is a molecular diagnostics company that develops and provides diagnostic, prognostic, and predictive tests that helps physicians in the treatment of cancer patients. It offers CancerTYPE ID, a gene expression test for metastatic patients with diagnostic ambiguity, and Breast Cancer Index, a tool for breast cancer patients. ontstopper pomp actionWebFind bioTheranostics Salaries by Job Title. 27 salaries (for 22 job titles) Updated 9/16/2024. How much do bioTheranostics employees make? Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips. ontstoken tandvlees antibioticaWebBiotheranostics was acquired by Hologic in February 2024, and continues to offer its portfolio of proprietary genomic assays to support personalized disease management in … Biotheranostics Nondiscrimination Notice. Download our PDF to view this notice in … iot by arshdeep bahga pdf